by 
The demand for decongestants is growing significantly owing to the increasing prevalence of common cold, sinusitis, nasal congestion and other respiratory diseases across the globe. Decongestants act by constricting the blood vessels in the nasal passages, thus reducing swelling and blocking the histamine receptors to relieve nasal congestion. They are available in various forms like tablets, liquids, sprays and capsules. The global decongestant market is estimated to be valued at US$ 4,710.4 Mn in 2024 and is expected to exhibit a CAGR of 18% over the forecast period 2023 to 2030.
Key Takeaways
Key players operating in the decongestant market are Johnson & Johnson, Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Sanofi S.A., Bayer AG, Reckitt Benckiser Group plc. The key players are focusing on new product launches and acquisitions to strengthen their market position.
There is high growth potential in developing regions due to increasing adoption of OTC drugs and expansion of e-commerce channels. Growing awareness about the benefits of nasal decongestants is also fueling the market growth.
With increasing pollution levels and changing lifestyles, the prevalence of respiratory diseases is rising globally. Major players are expanding their geographical footprint in high potential markets like Asia Pacific and Latin America through partnerships and joint ventures.
Market drivers
The widespread prevalence of common cold and seasonal allergies across all age groups is a major factor driving the demand for decongestants. According to WHO, on an average adults suffer 2-4 colds per year while children may get 6-10 colds annually. Growing pollution levels along with changing climate conditions have led to a significant rise in allergies worldwide. In addition, rising awareness about the benefits of OTC drugs for temporary relief from nasal congestion and accessibility through multiple distribution channels are boosting the market growth.
PEST Analysis
Political: Regulations regarding the manufacture and sale of decongestant medicines may impact the market. Government policies related to healthcare spending can also influence market growth.
Economic: Rise in disposable incomes and healthcare spending is likely to boost sales. However, economic slowdowns may negatively impact the market.
Social: Increasing adoption of self-medication owing to congestion issues will drive demand. Changing lifestyles leading to stress and lack of rest can increase such problems.
Technological: Developments in drug delivery technologies allow for products with improved efficacy and reduced side effects. Advancements in active ingredients help address problems better.
The North American region currently holds the largest share of the decongestant market in terms of value. This can be attributed to factors like high healthcare spending, easy availability of products, and growing prevalence of respiratory issues. The Asia Pacific region is anticipated to witness the fastest growth over the forecast period owing to a rising middle class population, growth in medical tourism, increasing healthcare access and expenditures in developing countries.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
